HPMC/PVP Dissolving Microneedles: a Promising Delivery Platform to Promote Trans-Epidermal Delivery of Alpha-Arbutin for Skin Lightening

被引:60
作者
Aung, Nway Nway [1 ]
Ngawhirunpat, Tanasait [1 ]
Rojanarata, Theerasak [1 ]
Patrojanasophon, Prasopchai [1 ]
Opanasopit, Praneet [1 ]
Pamornpathomkul, Boonnada [2 ]
机构
[1] Silpakorn Univ, PDGIG, Fac Pharm, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand
[2] Rajamangala Univ Technol Thanyaburi, Thai Tradit Med Coll, Thanyaburi 12130, Pathum Thani, Thailand
关键词
dissolving microneedles; alpha-arbutin; skin lightener; inhibit tyrosinase; IN-VITRO; MODEL MEMBRANE; PERMEATION; METHYLCELLULOSE; HYDRATION; PIG;
D O I
10.1208/s12249-019-1599-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alpha-arbutin is one of the most efficient skin lightener agents, which shows the effect on reducing the pigmentation by competitively inhibiting human tyrosinase. However, alpha-arbutin has difficulty in skin permeability due to its hydrophilic property. The objective of this study was, therefore, to develop alpha-arbutin-loaded dissolving microneedles (DMNs) for improving the delivery of alpha-arbutin into the skin. The DMN patch was prepared using Gantrez (TM) S-97, hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone K-90 (PVP), chitosan, and their combinations. The optimal 8% alpha-arbutin-loaded DMNs, aside from Gantrez (TM) S-97, was successfully formulated with combination of 8% w/w HPMC and 40% w/w PVP K-90 (HPMC/PVP) at the weight ratio of 1:1. Both DMNs had 100% of penetration into porcine skin. Over 12 h of skin permeation, the flux of Gantrez (TM) S-97 DMNs and the HPMC/PVP DMNs were 66.21 mu g/cm(2)/h and 74.24 mu g/cm(2)/h, respectively. The accumulation amount of alpha-arbutin in the skin from Gantrez (TM) S-97 DMNs and HPMC/PVP DMNs was 107.76 mu g and 312.23 mu g, respectively. In comparison to the gel formulations, Gantrez (TM) S-97 DMNs and HPMC/PVP DMNs increase the delivery of alpha-arbutin across the skin approximately 2 and 4.7 times, respectively. In vivo studies found that alpha-arbutin-loaded HPMC/PVP DMNs delivered more alpha-arbutin into the skin than commercial cream. Moreover, the skin can reseal naturally after removal of DMNs patch without any signs of infection and remain stable in accelerated conditions for 4 weeks. Accordingly, alpha-arbutin-loaded HPMC/PVP DMNs could be a promising delivery platform for promoting trans-epidermal delivery of alpha-arbutin for skin lightening.
引用
收藏
页数:13
相关论文
共 31 条
[1]   Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum [J].
Alkilani, Ahlam Zaid ;
McCrudden, Maeliosa T. C. ;
Donnelly, Ryan F. .
PHARMACEUTICS, 2015, 7 (04) :438-470
[2]  
[Anonymous], IMPROVEMENT ARBUTIN
[3]   Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs [J].
Baghel, Shrawan ;
Cathcart, Helen ;
O'Reilly, Niall J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (09) :2527-2544
[4]   Optimization and Evaluation of a Chitosan/Hydroxypropyl Methylcellulose Hydrogel Containing Toluidine Blue O for Antimicrobial Photodynamic Inactivation [J].
Chen, Chueh-Pin ;
Hsieh, Chien-Ming ;
Tsai, Tsuimin ;
Yang, Jen-Chang ;
Chen, Chin-Tin .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09) :20859-20872
[5]  
Cilurzo F, 2007, AAPS PHARMSCITECH, V8
[6]  
Couteau C., Cosmetics, DOI [10.3390/cosmetics3030027, DOI 10.3390/COSMETICS3030027]
[7]   Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies [J].
Davies, DJ ;
Ward, RJ ;
Heylings, JR .
TOXICOLOGY IN VITRO, 2004, 18 (03) :351-358
[8]   Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of the use of α-arbutin in cosmetic products [J].
Degen, Gisela H. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2016, 74 :75-76
[9]   Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe [J].
Desmedt, B. ;
Courselle, P. ;
De Beer, J. O. ;
Rogiers, V. ;
Grosber, M. ;
Deconinck, E. ;
De Paepe, K. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (06) :943-950
[10]   Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper-Lin small composite design [J].
El-Say, Khalid Mohamed .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 :825-839